Working… Menu
Trial record 1 of 1 for:    04665076
Previous Study | Return to List | Next Study

Multicenter Clinical Study on the Safety and Effectiveness of CAR-T in the Treatment of Relapsed/Refractory Plasma Cell Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04665076
Recruitment Status : Recruiting
First Posted : December 11, 2020
Last Update Posted : December 11, 2020
Hebei Medical University Fourth Hospital
Information provided by (Responsible Party):
Hebei Senlang Biotechnology Inc., Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 21, 2023
Estimated Study Completion Date : October 21, 2025